• en
  • it
  • de
  • News Archive

    CEO speaks at 25th Anniversary of PharmaZell plant in Chennai

    CEO speaks at 25th Anniversary of PharmaZell plant in Chennai

    Despite all restrictions and taking into account the COVID regulations, CEO Dr. Bolzern  did not miss the opportunity to attend the celebration of the 25th anniversary of the PharmaZell Group...

    New PharmaZell Trainees in Raubling /Germany

    New PharmaZell Trainees in Raubling /Germany

    In September seven young employees started their traineeship at the PharmaZell site Raubling (Germany). As one of their first joint activities they elected their new youth and trainee representative (JAV...

    Novel Food Ingredient registration         – synthetic CBD

    Novel Food Ingredient registration – synthetic CBD

    We are pleased to announce that the activities on synthetic CBD at our Farmabios site are progressing smoothly. The API is produced at a commercial batch size using a THC-free...

    Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios

    Private Equity owner Bridgepoint visits PharmaZell Group’s company Farmabios

    In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy). Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were...

    PharmaZell (India) Private Limited. – Vizag

    PharmaZell (India) Private Limited. – Vizag

    Vizag Unit has got approval from Board to expand 5ASA for one more separate 180 TPA manufacturing facility. Site clearance is given and the Civil work inaugural was organised on...

    We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility

    We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility

    We are very glad to announce that AIFA renewed the complete GMP certificate for Farmabios on July 7th 2020 SpA facility

    Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)

    Farmabios expands its Manufacturing Footprint in Gropello Cairoli (Italy)

    The construction of a brand new large steroid building and a new warehouse on the Farmabios premises in Gropello Cairoli (Italy) is moving forward nearly in plan. After construction work...

    Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.

    Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.

    Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very...

    CURRENT COVID-19 OUTBREAK: SUPPORTIVE HELP

    CURRENT COVID-19 OUTBREAK: SUPPORTIVE HELP

    Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as...

    UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES

    UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES

    PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to...

    FarmaBios activities are regularly proceeding…

    FarmaBios activities are regularly proceeding…

    During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part...

    Breaking News: PharmaZell Group acquired by Bridgepoint

    Breaking News: PharmaZell Group acquired by Bridgepoint

    The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint...

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)

    As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on...

    Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)

    We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].

    Farmabios expands its portfolio with Cannabidiol API

    Farmabios expands its portfolio with Cannabidiol API

    Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios...

    search for what
    Generic filters
    Exact matches only